Talk to the people behind the exciting things we do at Bidwells.

Our people

    Sorry, there were no results for your search. Please try again loader
      Life Sciences 2030
      What we do/ Life Sciences 2030

      Life Sciences 2030

      We are witnessing an evolution of the life science sector both in the UK and internationally. Not only is the sector expanding rapidly but scientific developments are facilitating new techniques and product outputs. Unsurprisingly, this is driving growing interest in the sector from real estate developers and investors alike, evident across the Oxford – Cambridge Arc as a global cluster of expertise in the life science sector.

      Credits: Bio-Innovation Centre, TusPark, Cambridge Science Park; Babraham Research Campus; Sherard Building, Oxford Science Park

      The UK's quest to become a Scientific Superpower is being led by Life Sciences.

      Major steps forward will be made in the coming decade, that seems certain, presenting huge opportunities for real estate investors and developers.

      But the nature of scientific research is inherently uncertain. Making a deeper understanding of the sector's changing specialist requirements an essential part of Life Sciences' real estate investment.

      Our Life Sciences 2030 report out today outlines how AI, robotics and specialist manufacturing will transform real estate requirements over the coming years, helping to direct development and investment into a sector on the brink of significant change.

      The report explains why Biopharma, Diagnostics, Medical devices, Digital Health and Bioprocessing are our Ones to Watch in the 2020s.

      And why being flexible and adaptable will help mitigate financial risk, support viability and maximise the opportunities presented by the UK’s exploding Life Sciences sector.

      Download our report

      Sign me up for future updates
      Yes No
      Science and Technology

      Privacy notice


      How will the application of AI in the life science sector impact on the demand for labs?

      The first in this series looks at the advances in AI, how these will be applied in the life sciences sector and raises some questions about implications for future lab space.
      Key Contacts

      Get in touch with our team

      Our R&D Business Survey (2021) was undertaken with YouGov. We are also indebted to life science specialist Anil Vaidya at Ten93 for working with us on this report.


      Our Science & Technology capabilities

      Investing in Science & Technology

      Science campus and innovation district asset management

      Developing science & technology assets

      Occupier consultancy